Why the study?
What is the incidence and clinical presentation of ball variance in patients who underwent aortic replacement with the model 1000 series Starr-Edwards valve?
What is the incidence and clinical presentation of ball variance in patients who underwent aortic replacement with the model 1000 series Starr-Edwards valve?
A high incidence of ball variance (75%) was observed in long-term survivors with the model 1000 series Starr-Edwards aortic valve, highlighting a significant device-related safety issue.
Answers are grounded in this paper and cite their sources.
Survivors with model 1000 Starr-Edwards aortic valves warrant monitoring for ball variance; leaves open durability questions for contemporary prosthesis research.
Increased incidences of acute valvular malfunction and of death due to changes in the silicone poppet of cardiac valve prostheses have been noted. Of the 47 long-term survivors of aortic replacement with the model 1000 series Starr-Edwards valve operated upon in a 1-year period beginning July 1, 1963, 40 patients have been available for follow-up. Of these, ball variance has been demonstrated by autopsy or reoperation in 30 (75%). Ball variance was noted at autopsy in 7 cases (18%) and was considered the cause of death in 5 (13%). The symptoms of ball variance are nonspecific and include fatigue, dyspnea on exertion, palpitation, dizzy spells, angina, and syncopal episodes. The diagnosis of aortic ball variance is based on the absence of the aortic opening sound; a consistently abnormal phonocardiogram or sound spectrogram, or both; recurrent embolic episodes; and late onset of aortic regurgitation or radiographic evidence of an abnormal barium-impregnated poppet, or both. Ball variance in the mitral prosthesis is also discussed.
No takes yet. Share an insight, caveat, or question.
John C. Hylen (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: